Company Information

Company Profile

Cerecor is a clinical-stage biopharmaceutical company developing innovative drug candidates to make a difference in the lives of patients with neurological and psychiatric disorders. Cerecor is currently pursuing the development of two clinical Phase 2-stage product candidates, CERC-301 and CERC-501; as well as two earlier stage programs.

Latest Presentation

Investor Presentation

View This Presentation
Investor Presentation

Contact Information

Investor Relations

Company Contact
Cerecor, Inc.
400 East Pratt Street
Baltimore, MD 21202